Clinical trial

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

NCT04312698

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention D013, D326, D337 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo of D013, D326, D337 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention D013, placebo of D326, placebo of D337 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-08-29

PhasePHASE3

Conditions

Dyslipidemia Patients With Hypertensionunresolved

Interventions

D013, D326, D337DRUG

placebo of D013, D326, D337DRUG

D013, placebo of D326, placebo of D337DRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04312698 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.